The private equity inflows in H1 of 2015 point to the higher interest generated in terms of number of deals which have gone up by 62 per-cent, every year. In value terms, the deal sizes this year compare quite good against USD 5.11 billion in the same period of 2014 and USD 5.64 in the year before, the study noted, collecting various transactions.ClickFree stock tips
When it comes to mergers and acquisitions, there have been around 277 M&A deals (excluding Private Equity) valuing around USD 15.8 billion in the H1, 2015 against 269 valued around USD 17.2 billion in 2014, when a quantum jump was provided by the Sun Pharma - Ranbaxy mega merger worth USD 3.2 billion.The M&As had aggregated 255 for the corresponding period of 2013 worth USD 12 billion.
The top-3 sectors dominating the M&A situation in H1 2015 are IT & ITES (38 pc) followed by Banking & Financials Services (14 pc), Pharma, Healthcare & Biotech (11 pc) and others. While the M&A opportunities remain robust, especially when there are companies on the block with high level of leverage, boosted interest by the private equity players certainly remains a notable point, said by Assocham Secretary General D S Rawat.
When it comes to mergers and acquisitions, there have been around 277 M&A deals (excluding Private Equity) valuing around USD 15.8 billion in the H1, 2015 against 269 valued around USD 17.2 billion in 2014, when a quantum jump was provided by the Sun Pharma - Ranbaxy mega merger worth USD 3.2 billion.The M&As had aggregated 255 for the corresponding period of 2013 worth USD 12 billion.
The top-3 sectors dominating the M&A situation in H1 2015 are IT & ITES (38 pc) followed by Banking & Financials Services (14 pc), Pharma, Healthcare & Biotech (11 pc) and others. While the M&A opportunities remain robust, especially when there are companies on the block with high level of leverage, boosted interest by the private equity players certainly remains a notable point, said by Assocham Secretary General D S Rawat.
No comments:
Post a Comment